United Therapeutics
Clinical trials sponsored by United Therapeutics, explained in plain language.
-
Pig kidney transplants begin: a lifeline for kidney patients?
Disease control Recruiting nowThis study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or are unlikely to receive one in time. Participants will receive the pig kidney and be followed for at least 24 we…
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 01, 2026 12:28 UTC
-
New inhaled therapy could help thousands with scarred lungs
Disease control Recruiting nowThis study tests an inhaled medication called treprostinil in people with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. About 698 adults will receive either the drug or a placebo for 52 weeks. The main goal is to see if the drug improves lung …
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 01, 2026 12:25 UTC
-
Pig kidney transplants begin in humans: a lifeline for those who Can't get a human donor?
Disease control Recruiting nowThis study tests whether a specially modified pig kidney (called a thymokidney) can safely work in people with end-stage kidney disease who cannot get a human kidney transplant. About 50 participants will receive the pig kidney and be followed for life to check survival, kidney f…
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New study aims to catch hidden Heart-Lung danger early
Diagnosis Recruiting nowThis study looks at ways to screen for pulmonary hypertension (high blood pressure in the lungs) in people with interstitial lung disease (scarring of the lungs). The goal is to find this complication earlier. About 300 adults with ILD will be tested using heart catheterization t…
Sponsor: United Therapeutics • Aim: Diagnosis
Last updated May 01, 2026 12:27 UTC
-
New registry aims to unlock secrets of rare lung disease combo
Knowledge-focused Recruiting nowThis study is a patient registry that will collect real-world information from 900 adults with both pulmonary hypertension (high blood pressure in the lungs) and interstitial lung disease (lung scarring). The goal is to better understand the patients' backgrounds, medical history…
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC